• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于亚临床甲状腺功能亢进自然病史的观察

Observations concerning the natural history of subclinical hyperthyroidism.

作者信息

Woeber Kenneth A

机构信息

University of California, San Francisco, San Francisco, California 94143-1640, USA.

出版信息

Thyroid. 2005 Jul;15(7):687-91. doi: 10.1089/thy.2005.15.687.

DOI:10.1089/thy.2005.15.687
PMID:16053385
Abstract

OBJECTIVE

To examine the natural history of a subnormal serum thyroid-stimulating hormone (TSH) concentration with normal concentrations of both serum free thyroxine (FT4) and free triiodothyronine (FT3) (subclinical hyperthyroidism). PATIENTS, DESIGN, AND MEASUREMENTS: A retrospective analysis was undertaken and yielded 16 ambulatory patients who had presented with subclinical hyperthyroidism and were longitudinally followed with measurements of serum TSH and both FT4 and FT3 for a cumulative follow-up of 11 to 36 months. Seven of the patients had subclinical Graves' hyperthyroidism as judged from the presence of thyroid-stimulating immunoglobulins (TSI) in serum, and 9 had multinodular goiter confirmed with ultrasound and no TSI.

RESULTS

In the 7 patients with TSI, serum TSH reverted to normal in 5 patients, with disappearance or decrease of TSI in 4, within 3 to 19 months. In 1 patient, subnormal serum TSH accompanied by both normal FT4 and FT3 has persisted for 15 months, and in a second patient serum TSH reverted to normal within 9 months, but at follow-up 27 months later overt hyperthyroidism had emerged. In the 9 patients with multinodular goiter, subnormal serum TSH accompanied by both normal FT4 and FT3 persisted during cumulative follow-up that ranged from 11 to 36 months.

CONCLUSIONS

This study suggests that the natural history of subclinical hyperthyroidism is variable, resolving or occasionally evolving in subclinical Graves' disease and persisting unchanged in multinodular goiter.

摘要

目的

研究血清促甲状腺激素(TSH)浓度低于正常范围而血清游离甲状腺素(FT4)和游离三碘甲状腺原氨酸(FT3)浓度正常(亚临床甲亢)的自然病程。患者、设计与测量:进行回顾性分析,纳入16例门诊患者,这些患者表现为亚临床甲亢,并对其进行纵向随访,测量血清TSH、FT4和FT3,累计随访时间为11至36个月。根据血清中存在甲状腺刺激免疫球蛋白(TSI)判断,7例患者为亚临床格雷夫斯甲亢,9例经超声证实为多结节性甲状腺肿且无TSI。

结果

在7例有TSI的患者中,5例患者的血清TSH在3至19个月内恢复正常,4例患者的TSI消失或降低。1例患者血清TSH低于正常范围且FT4和FT3均正常的情况持续了15个月,另1例患者血清TSH在9个月内恢复正常,但在27个月后的随访中出现了显性甲亢。在9例多结节性甲状腺肿患者中,血清TSH低于正常范围且FT4和FT3均正常的情况在11至36个月的累计随访期间持续存在。

结论

本研究表明,亚临床甲亢的自然病程是可变的,在亚临床格雷夫斯病中可缓解或偶尔进展,而在多结节性甲状腺肿中则持续不变。

相似文献

1
Observations concerning the natural history of subclinical hyperthyroidism.关于亚临床甲状腺功能亢进自然病史的观察
Thyroid. 2005 Jul;15(7):687-91. doi: 10.1089/thy.2005.15.687.
2
Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.亚临床甲状腺功能亢进的格雷夫斯病患者骨转换持续增加。
J Clin Endocrinol Metab. 2000 Nov;85(11):4157-61. doi: 10.1210/jcem.85.11.6979.
3
The many causes of subclinical hyperthyroidism.亚临床甲状腺功能亢进的多种病因。
Thyroid. 1996 Oct;6(5):391-6. doi: 10.1089/thy.1996.6.391.
4
Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.敏感促甲状腺激素测量的临床经验:诊断和治疗意义
J Nucl Med. 1985 Nov;26(11):1248-56.
5
Follow-up of newborns of mothers with Graves' disease.对患有 Graves 病的母亲所生新生儿的随访。
Thyroid. 2014 Jun;24(6):1032-9. doi: 10.1089/thy.2013.0489. Epub 2014 Mar 17.
6
Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.游离甲状腺素和三碘甲状腺原氨酸水平未升高情况下的格雷夫斯眼病:患病率、自然病程及促甲状腺素受体抗体水平
Thyroid. 2000 Dec;10(12):1093-100. doi: 10.1089/thy.2000.10.1093.
7
Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.甲状腺功能亢进型格雷夫斯病缓解期患者的甲状腺功能及免疫参数研究。
J Clin Endocrinol Metab. 1988 Jan;66(1):103-8. doi: 10.1210/jcem-66-1-103.
8
Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study.老年患者 TSH 在 0.1 至 0.4mIU/L 之间的亚临床甲状腺功能亢进的自然病史:一项前瞻性研究。
Clin Endocrinol (Oxf). 2010 May;72(5):685-8. doi: 10.1111/j.1365-2265.2009.03696.x.
9
Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.采用灵敏检测法测定的2型糖尿病患者促甲状腺激素浓度异常的患病率。
Diabetes Res. 1994;27(1):15-25.
10
Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.亚临床格雷夫斯病作为甲状腺功能正常者促甲状腺激素水平低于正常的原因。
J Endocrinol Invest. 1997 Apr;20(4):183-8. doi: 10.1007/BF03346900.

引用本文的文献

1
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis.阿仑单抗诱导的多发性硬化症甲状腺事件:系统评价和荟萃分析。
J Endocrinol Invest. 2020 Feb;43(2):219-229. doi: 10.1007/s40618-019-01105-7. Epub 2019 Aug 26.
2
Stability of thyroid function in older adults: the Birmingham Elderly Thyroid Study.老年人甲状腺功能的稳定性:伯明翰老年甲状腺研究。
Br J Gen Pract. 2018 Oct;68(675):e718-e726. doi: 10.3399/bjgp18X698861. Epub 2018 Aug 28.
3
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism.
2015年欧洲甲状腺协会关于内源性亚临床甲状腺功能亢进症诊断和治疗的指南。
Eur Thyroid J. 2015 Sep;4(3):149-63. doi: 10.1159/000438750. Epub 2015 Aug 26.
4
Management of subclinical hyperthyroidism.亚临床甲状腺功能亢进的管理。
Int J Endocrinol Metab. 2012 Spring;10(2):490-6. doi: 10.5812/ijem.3447. Epub 2012 Apr 20.
5
United detection GNAS and TSHR mutations in subclinical toxic multinodular goiter.联合检测毒性多结节性甲状腺肿的亚临床患者中的 GNAS 和 TSHR 突变。
Eur Arch Otorhinolaryngol. 2010 Feb;267(2):281-7. doi: 10.1007/s00405-009-1051-3.